The Electronic Medication Complete Communication (EMC2) Study: Rationale and Methods for a Randomized Controlled Trial of a Strategy to Promote Medication Safety in Ambulatory Care

摘要

BackgroundAdverse drug events (ADEs) affect millions of patients annually and place a significant burden on the healthcare system. The Food and Drug Administration (FDA) has developed patient safety information for high-risk medications that pose serious public health concerns. However, there are currently few assurances that patients receive this information or are able to identify or respond correctly to ADEs.